Mary Motyl | Director of Clinical Microbiology
Merck & Co

Mary Motyl, Director of Clinical Microbiology, Merck & Co

Board-certified Clinical Microbiologist; before coming to Merck was the Director of Clinical Microbiology at Beth Israel Medical Center in NYC. At Merck is in the Basic Research Discovery and Development group and is  part of Merck’s Antimicrobial Susceptibility Testing Development Team.

Appearances:



World Anti-Microbial Resistance Congress USA 2018 - Day 2 @ 11:30

Ensuring availability of approved susceptibility tests

  • Working with all stakeholders in susceptibility testing development, pharmaceutical companies, device manufacturer, clinical microbiology lab and physicians
  • Historical delays and potential solutions to streamline testing approvals and availability
  • Issues of research use only (RUO) testing devises
last published: 19/Oct/18 16:35 GMT

back to speakers